Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EBP | Q15125 | 2/20 | 0.36 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7972060 | 0.89 | EBP (0.36) | EBPSIGMAR1KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL7955856 | 0.89 | EBP (0.36) | EBPSIGMAR1L3MBTL1 | |
| SCHEMBL7968608 | 0.88 | EBP (0.39) | EBPSIGMAR1L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL7966552 | 0.88 | EBP (0.38) | EBPSIGMAR1L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL7966575 | 0.87 | EBP (0.36) | EBPSIGMAR1L3MBTL1 | |
| SCHEMBL7966875 | 0.87 | EBP (0.36) | EBPSIGMAR1L3MBTL1KDM4EALDH1A1 | |
| SCHEMBL7966872 | 0.87 | EBP (0.36) | EBPSIGMAR1L3MBTL1 | |
| SCHEMBL7965792 | 0.85 | EBP (0.35) | EBPSIGMAR1L3MBTL1 | |
| SCHEMBL7956183 | 0.85 | EBP (0.38) | EBPSIGMAR1L3MBTL1KDM4E | |
| SCHEMBL7956069 | 0.85 | EBP (0.43) | EBPSIGMAR1KCNA5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6265439-B1 | Halogenated phenylacetonitrile alkylaminoalkylphenyl compounds as immunosuppressives | G.D. SEARLE & CO. | 2001-07-24 | — | — | US | disclosed |
| US-5451604-A | Useful in organ transplant surgery | G. D. SEARLE & CO. (US) | 1995-09-19 | — | — | US | disclosed |